Tilray Brands (TLRY) Stock Price, News & Analysis

Company Overview

Tilray Brands, Inc. ('Tilray') (Nasdaq: TLRY; TSX: TLRY), is a global lifestyle and consumer packaged goods company at the forefront of beverage, cannabis and wellness industries with operations in Canada, the United States, Europe, Australia, and Latin America that is leading as a transformative force at the nexus of cannabis, beverage, wellness, and entertainment, elevating lives through moments of connection. Tilray's mission is to be a leading premium lifestyle company with a house of brands and innovative products that inspire joy, wellness and create memorable experiences. Tilray's unprecedented platform supports over 40 brands in over 20 countries, including comprehensive cannabis offerings, hemp-based foods, and craft beverages.

Key Stats

• Today's Range: C$7.38 to C$7.53
• 50-Day Range: C$7.18 to C$10.82
• 52-Week Range: C$4.90 to C$32.30
• Volume: 93,199 shs
• Average Volume: 568,603 shs
• Market Capitalization: C$897.03 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: C$13.30
• Consensus Rating: Hold

Tilray Brands Stock Analysis - MarketRank™

Tilray Brands scored higher than 26% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.0 / 5
• Analyst Rating: Hold

Consensus Rating

Tilray Brands has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, no buy ratings, 1 hold rating, and no sell ratings.

Upside Potential

Tilray Brands has a consensus price target of C$13.30, representing about 77.3% upside from its current price of C$7.50.

Amount of Analyst Coverage

Tilray Brands has received no research coverage in the past 90 days.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Tilray Brands is -0.51, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Tilray Brands is -0.51, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Tilray Brands has a P/B Ratio of 0.55. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: N/A
• Short Interest Level: N/A

Short Interest

There is no current short interest data available for TLRY.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Tilray Brands does not currently pay a dividend.

Dividend Growth

Tilray Brands does not have a long track record of dividend growth.

News and Social Media

• Score: 0.6 / 5
• News Sentiment: N/A

Search Interest

38 people have searched for TLRY on MarketBeat in the last 30 days. This is an increase of 73% compared to the previous 30 days.

Company Ownership

• Score: 0.1 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Tilray Brands insiders have not sold or bought any company stock.

Percentage Held by Insiders

0.69% of the stock of Tilray Brands is held by insiders.

Percentage Held by Institutions

4.08% of the stock of Tilray Brands is held by institutions.

Industry, Sector and Symbol

• Stock Exchange: TSE
• Sector: Medical
• Industry: Drug Manufacturers - Specialty & Generic
• Sub-Industry: Pharmaceutical Products
• Current Symbol: TSE:TLRY
• Previous Symbol: TSE:TLRY
• CIK: N/A
• Web: www.tilray.com
• Phone: 12064329325
• Fax: N/A
• Employees: 2,650
• Year Founded: N/A

Price Target and Rating

• Average Price Target for Tilray Brands: C$13.30
• High Price Target: C$13.60
• Low Price Target: C$13.00
• Potential Upside/Downside: +77.3%
• Consensus Rating: Hold
• Rating Score (0-4): 2.00
• Research Coverage: 1 Analysts

Profitability

• EPS (Trailing Twelve Months): C($14.63)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -C$183.24 million
• Net Margins: -158.75%
• Pretax Margin: N/A
• Return on Equity: -88.06%
• Return on Assets: -1.41%

Debt

• Debt-to-Equity Ratio: 20.36
• Current Ratio: 2.79
• Quick Ratio: 2.16

Sales & Book Value

• Annual Sales: C$858.28 million
• Price / Sales: 1.05
• Cash Flow: C$1.26 per share
• Price / Cash Flow: 5.95
• Book Value: C$13.54 per share
• Price / Book: 0.55

Miscellaneous

• Outstanding Shares: 119,604,000
• Free Float: N/A
• Market Cap: C$897.03 million
• Optionable: Not Optionable
• Beta: 3.24